Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BrainGene AB
AB
Active
Org 5569002636
Vipemöllevägen 103, 224 66
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2012
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BrainGene AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
0
0
0
0
—
Staff expenses
—
—
—
—
—
EBITDA
−62
−53
−51
−84
−137
Depreciation & amort.
−6
−6
−10
−20
−368
EBIT
−68
−59
−61
−104
−505
Net financials
—
—
—
—
0
Profit before tax
0
−59
39
96
−304
Tax
−0
−0
−0
−0
—
Net profit
0
−59
39
96
−304
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
859
970
1 516
1 495
1 291
Equity
91
32
171
267
263
Long-term debt
0
0
0
1 203
1 003
Short-term debt
768
937
1 345
24
25
Total debt
768
937
1 345
1 227
1 028
Financial ratios
5-year trend
EBITDA margin
-13672900.0%
This company
15.8%
Market median
-86537442% vs market
2021
2025
Equity ratio
20.3%
This company
38.2%
Market median
-47% vs market
2021
2025
Return on equity
-116.0%
This company
18.4%
Market median
-730% vs market
2021
2025
Net profit margin
-30449400.0%
This company
8.1%
Market median
-375918619% vs market
2021
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2021
2025
Debt / equity
3.92×
This company
0.62×
Market median
-532% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on BrainGene AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
